Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|July 2, 2011
Evolving therapeutic paradigms for advanced prostate cancerJoshua M Ruch, Maha H HussainDrugs|April 23, 2013
Hedgehog signaling pathway and cancer therapeutics: progress to dateJoshua M Ruch, Edward J KimOncology (Williston Park, N.Y.)|May 19, 2016
Targeting PARP in Prostate Cancer: Novelty, Pitfalls, and PromisePhillip L Palmbos, Maha H HussainCurrent Opinion in Oncology|March 21, 2013
Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancerGary R MacVicar, Maha H HussainExpert Review of Anticancer Therapy|July 13, 2002
Hormonal therapy for prostate cancer: past, present and futureBasil F el-Rayes, Maha H HussainAcademic Radiology|November 30, 2025
Yttrium-90 Radioembolization for Androgen-Independent Prostate Cancer Metastasis to the LiverMohamad M Alzein, Andrew C Gordon, Maha H Hussain, et al.American Journal of Clinical Oncology|November 5, 2015
A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary CancersElizabeth J Davis, Kent A Griffith, Edward J Kim, et al.Clinical Genitourinary Cancer|May 27, 2008
Phase II open-label study of oral piritrexim in patients with advanced carcinoma of the urothelium who have experienced failure with standard chemotherapyLance K Lassiter, Mohan K Tummala, Maha H Hussain, et al.Clinical & Experimental Metastasis|December 18, 2012
Integrin alpha2beta 1 (α2β1) promotes prostate cancer skeletal metastasisJoseph L Sottnik, Stephanie Daignault-Newton, Xiaotun Zhang, et al.Cancer|June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.Pageof 3